November 2024 Stock Losers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2024-11-27, 19 of 20 completed market sessions produced ranked moves. Follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of November 2024

100

Ranked drops

-83.78%

Largest, SAVA

92.6%

Below baseline, day +5

3.1%

Median recovered, day +5

Filter and sort

100 ranked drops in November 2024

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	SAVA	-83.78%	2024-11-25 against the close of 2024-11-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Cassava Sciences to Hold Corporate Update on November 25th 11/24/2024 20:01 ET after hours Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints 11/25/2024	Day +1 -85.56% 2024-11-26 Day +5 -87.35% 2024-12-03 Best recovery within 5 -84.97% 2024-11-27 The drop was 4.3% larger five sessions later. Month end -85.50% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $26.48 to $4.30 Session open, high, low $4.02, $4.99, $3.70 Opening gap -84.82% Close inside the session range 0.46 of the range, where 1.00 is the high Session volume 94,720,293 shares, $406,823,658 Relative volume 67.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
2	EYEN	-70.04%	2024-11-15 against the close of 2024-11-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Eyenovia Provides Update on Phase 3 CHAPERONE Study 11/15/2024 07:00 ET premarket	Day +1 -67.36% 2024-11-18 Day +5 -68.36% 2024-11-22 Best recovery within 5 -64.95% 2024-11-19 2.4% of the drop was recovered five sessions later. Month end -70.89% on 2024-11-29
Close before and after $27.21 to $8.15 Session open, high, low $10.88, $10.88, $6.89 Opening gap -60.01% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 660,001 shares, $5,380,328 Relative volume 66.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
3	AILEW	-66.54%	2024-11-18 against the close of 2024-11-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	iLearningEngines Announces Leadership Appointments 11/18/2024 09:30 ET intraday	Day +1 -55.88% 2024-11-19 Day +5 -33.74% 2024-11-25 Best recovery within 5 -33.74% 2024-11-25 49.3% of the drop was recovered five sessions later. Month-end is not shown: no closing price is available for 2024-11-29.
Close before and after $0.1811 to $0.0606 Session open, high, low $0.1500, $0.1500, $0.0400 Opening gap -17.17% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 703,436 shares, $42,628 Relative volume 358.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
4	OTLK	-65.24%	2024-11-27 against the close of 2024-11-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Outlook Therapeutics® Announces Preliminary Topline Results of NORSE EIGHT Clinical Trial 11/27/2024 06:50 ET premarket	Day +1 -58.08% 2024-11-29 Day +5 -69.94% 2024-12-05 Best recovery within 5 -58.08% 2024-11-29 The drop was 7.2% larger five sessions later. Month end -58.08% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $4.89 to $1.70 Session open, high, low $0.9810, $2.21, $0.8700 Opening gap -79.94% Close inside the session range 0.62 of the range, where 1.00 is the high Session volume 62,276,313 shares, $105,869,732 Relative volume 272.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
5	CMAXW Also on the opposite board this month on both boards	-59.46%	2024-11-18 against the close of 2024-11-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CareMax Reaches Agreements to Sell Management Services Organization and Core Centers’ Assets 11/17/2024 18:17 ET after hours	Day +1 -36.04% 2024-11-19 Day +5 -11.71% 2024-11-25 Best recovery within 5 -11.71% 2024-11-25 80.3% of the drop was recovered five sessions later. Month-end is not shown: no closing price is available for 2024-11-29.
Close before and after $0.0111 to $0.0045 Session open, high, low $0.0076, $0.0076, $0.0042 Opening gap -31.53% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 157,739 shares, $710 Relative volume 48.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
6	SAVE	-59.32%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Spirit Airlines Files Form 12b-25 11/12/2024 18:49 ET after hours	Day +1 -59.01% 2024-11-14 Day +5 no data Best recovery within 5 so far -59.01% 2024-11-14 Month-end is not shown: no closing price is available for 2024-11-29.
Close before and after $3.22 to $1.31 Session open, high, low $1.15, $1.57, $1.13 Opening gap -64.29% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 76,053,555 shares, $99,630,157 Relative volume 6.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
7	SOWG	-56.78%	2024-11-14 against the close of 2024-11-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sow Good Reports Third Quarter 2024 Results 11/14/2024 08:00 ET premarket	Day +1 -61.67% 2024-11-15 Day +5 -59.43% 2024-11-21 Best recovery within 5 -59.43% 2024-11-21 The drop was 4.7% larger five sessions later. Month end -63.40% on 2024-11-29
Close before and after $147.15 to $63.60 Session open, high, low $88.50, $99.45, $58.80 Opening gap -39.86% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 193,912 shares, $12,332,803 Relative volume 50.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
8	IAUX	-56.07%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	i-80 Gold Reports Q3 2024 Operating Results and New Development Plan 11/12/2024 18:34 ET after hours	Day +1 -56.89% 2024-11-14 Day +5 -38.43% 2024-11-20 Best recovery within 5 -38.43% 2024-11-20 31.5% of the drop was recovered five sessions later. Month end -30.64% on 2024-11-29
Close before and after $0.9081 to $0.3989 Session open, high, low $0.5400, $0.5599, $0.3391 Opening gap -40.54% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 76,311,797 shares, $30,440,776 Relative volume 16.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
9	XFOR Also on the opposite board this month on both boards	-53.17%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) 11/13/2024 06:01 ET premarket X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update 11/13/2024	Day +1 -30.75% 2024-11-14 Day +5 -42.51% 2024-11-20 Best recovery within 5 -30.75% 2024-11-14 20.0% of the drop was recovered five sessions later. Month end -33.63% on 2024-11-29
Close before and after $17.76 to $8.32 Session open, high, low $15.53, $15.53, $7.84 Opening gap -12.60% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 617,921 shares, $5,140,485 Relative volume 14.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
10	CATX	-51.38%	2024-11-21 against the close of 2024-11-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium 11/21/2024 07:15 ET premarket	Day +1 -43.76% 2024-11-22 Day +5 -29.50% 2024-11-29 Best recovery within 5 -28.69% 2024-11-26 42.6% of the drop was recovered five sessions later. Month end -29.50% on 2024-11-29
Close before and after $6.17 to $3.00 Session open, high, low $4.47, $4.59, $2.94 Opening gap -27.55% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 12,632,282 shares, $37,896,846 Relative volume 20.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
11	SIDU	-47.11%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Sidus Space Announces Pricing of Public Offering 11/12/2024 21:11 ET after hours	Day +1 -43.11% 2024-11-14 Day +5 -45.33% 2024-11-20 Best recovery within 5 -42.67% 2024-11-19 3.8% of the drop was recovered five sessions later. Month end -33.33% on 2024-11-29
Close before and after $2.25 to $1.19 Session open, high, low $1.24, $1.29, $1.16 Opening gap -44.89% Close inside the session range 0.23 of the range, where 1.00 is the high Session volume 5,904,354 shares, $7,026,181 Relative volume 28.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
12	NVCT	-46.30%	2024-11-14 against the close of 2024-11-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer 11/14/2024 07:00 ET premarket	Day +1 -53.61% 2024-11-15 Day +5 -54.08% 2024-11-21 Best recovery within 5 -51.83% 2024-11-19 The drop was 16.8% larger five sessions later. Month end -52.76% on 2024-11-29
Close before and after $10.67 to $5.73 Session open, high, low $5.09, $6.55, $4.90 Opening gap -52.30% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 1,713,672 shares, $9,819,341 Relative volume 8.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
13	EVH	-45.62%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Evolent Announces Third Quarter 2024 Results 11/07/2024 16:10 ET after hours Humana and Evolent Expand Partnership to Enhance Oncology Care 11/07/2024	Day +1 -38.42% 2024-11-11 Day +5 -49.61% 2024-11-15 Best recovery within 5 -38.42% 2024-11-11 The drop was 8.7% larger five sessions later. Month end -47.42% on 2024-11-29
Close before and after $24.57 to $13.36 Session open, high, low $14.40, $15.51, $13.31 Opening gap -41.39% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 20,358,923 shares, $271,995,211 Relative volume 13.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
14	PYXS	-45.03%	2024-11-21 against the close of 2024-11-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data 11/20/2024 16:05 ET after hours	Day +1 -50.26% 2024-11-22 Day +5 -47.38% 2024-11-29 Best recovery within 5 -47.38% 2024-11-29 The drop was 5.2% larger five sessions later. Month end -47.38% on 2024-11-29
Close before and after $3.82 to $2.10 Session open, high, low $2.17, $2.39, $1.90 Opening gap -43.19% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 15,188,134 shares, $31,895,081 Relative volume 28.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
15	SEM	-44.86%	2024-11-26 against the close of 2024-11-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Concentra Announces Completion of Spin-Off from Select Medical 11/25/2024 17:30 ET after hours Select Medical Holdings Corporation Completes Spin-Off of Concentra 11/25/2024	Day +1 -47.42% 2024-11-27 Day +5 -46.98% 2024-12-04 Best recovery within 5 -45.45% 2024-11-29 The drop was 4.7% larger five sessions later. Month end -45.45% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $38.70 to $21.34 Session open, high, low $20.35, $21.36, $20.17 Opening gap -47.42% Close inside the session range 0.98 of the range, where 1.00 is the high Session volume 2,438,914 shares, $52,046,425 Relative volume 3.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	APPS	-44.75%	2024-11-07 against the close of 2024-11-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Digital Turbine Reports Fiscal 2025 Second Quarter Financial Results 11/06/2024 17:20 ET after hours	Day +1 -54.94% 2024-11-08 Day +5 -56.79% 2024-11-14 Best recovery within 5 -54.01% 2024-11-13 The drop was 26.9% larger five sessions later. Month end -55.56% on 2024-11-29
Close before and after $3.24 to $1.79 Session open, high, low $1.91, $1.97, $1.65 Opening gap -41.05% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 25,072,807 shares, $44,880,325 Relative volume 14.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
17	VRCA	-44.23%	2024-11-05 against the close of 2024-11-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition 11/04/2024 16:05 ET after hours	Day +1 -47.81% 2024-11-06 Day +5 -35.66% 2024-11-12 Best recovery within 5 -32.73% 2024-11-11 19.4% of the drop was recovered five sessions later. Month end -10.49% on 2024-11-29
Close before and after $14.30 to $7.98 Session open, high, low $9.30, $9.39, $7.47 Opening gap -34.97% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 368,865 shares, $2,941,698 Relative volume 11.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
18	NGNE More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-44.08%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Neurogene Reports Positive Interim Efficacy Data from First Four Low-Dose Pediatric Participants in NGN-401 Gene Therapy Clinical Trial for Rett Syndrome 11/11/2024 16:01 ET after hours	Day +1 -44.55% 2024-11-13 Day +5 -75.91% 2024-11-19 Best recovery within 5 -44.55% 2024-11-13 The drop was 72.2% larger five sessions later. Month end -64.45% on 2024-11-29
Close before and after $71.53 to $40.00 Session open, high, low $48.28, $49.37, $35.60 Opening gap -32.50% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 1,991,645 shares, $79,665,800 Relative volume 16.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
19	NGNE More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-42.58%	2024-11-18 against the close of 2024-11-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome 11/18/2024 06:45 ET premarket	Day +1 -50.08% 2024-11-19 Day +5 -35.35% 2024-11-25 Best recovery within 5 -35.35% 2024-11-25 17.0% of the drop was recovered five sessions later. Month end -26.32% on 2024-11-29
Close before and after $34.52 to $19.82 Session open, high, low $22.24, $23.79, $18.94 Opening gap -35.56% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 1,999,274 shares, $39,625,611 Relative volume 16.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
20	MQ	-42.52%	2024-11-05 against the close of 2024-11-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Marqeta Reports Third Quarter 2024 Financial Results 11/04/2024 16:05 ET after hours	Day +1 -36.13% 2024-11-06 Day +5 -30.92% 2024-11-12 Best recovery within 5 -30.42% 2024-11-11 27.3% of the drop was recovered five sessions later. Month end -34.79% on 2024-11-29
Close before and after $23.80 to $13.68 Session open, high, low $15.60, $15.80, $13.48 Opening gap -34.45% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 20,095,262 shares, $274,903,184 Relative volume 31.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
21	INSG	-40.36%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Inseego Reports Third Quarter 2024 Financial Results 11/12/2024 16:05 ET after hours Inseego Completes Material Debt Reduction in Closing Restructuring of Convertible Notes due 2025 11/12/2024	Day +1 -32.21% 2024-11-14 Day +5 -31.61% 2024-11-20 Best recovery within 5 -29.30% 2024-11-18 21.7% of the drop was recovered five sessions later. Month end -34.25% on 2024-11-29
Close before and after $18.16 to $10.83 Session open, high, low $13.60, $13.95, $10.52 Opening gap -25.11% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 1,583,392 shares, $17,148,135 Relative volume 9.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
22	RAPT	-39.45%	2024-11-11 against the close of 2024-11-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury 11/11/2024 08:00 ET premarket	Day +1 -39.79% 2024-11-12 Day +5 -61.94% 2024-11-18 Best recovery within 5 -39.79% 2024-11-12 The drop was 57.0% larger five sessions later. Month end -56.40% on 2024-11-29
Close before and after $23.12 to $14.00 Session open, high, low $12.16, $14.62, $10.44 Opening gap -47.40% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 930,011 shares, $13,020,154 Relative volume 33.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
23	BETRW release reads positive	-39.26%	2024-11-11 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 39.26%	Better.com Expands Mortgage Offerings for Veterans through VA Interest Rate Reduction Refinance Loan (VA IRRRL) 11/11/2024 09:00 ET premarket	Day +1 -31.57% 2024-11-14 Day +5 -39.95% 2024-11-27 Best recovery within 5 -31.57% 2024-11-14 The drop was 1.8% larger five sessions later. Month end -31.57% on 2024-11-29
Close before and after $0.1169 to $0.0710 Session open, high, low $0.0808, $0.1169, $0.0710 Opening gap -30.88% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 51,500 shares, $3,656 Relative volume 23.4x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
24	RMTI	-39.14%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter 11/12/2024 06:00 ET premarket	Day +1 -43.44% 2024-11-13 Day +5 -46.45% 2024-11-19 Best recovery within 5 -43.44% 2024-11-13 The drop was 18.7% larger five sessions later. Month end -50.75% on 2024-11-29
Close before and after $46.50 to $28.30 Session open, high, low $34.80, $36.20, $28.10 Opening gap -25.16% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 647,905 shares, $18,335,712 Relative volume 17.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
25	PACS More than one ranked move this month 2+ ranked moves	-38.76%	2024-11-06 against the close of 2024-11-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	PACS Group Provides Preliminary Third Quarter Operational Metrics 11/06/2024 06:00 ET premarket	Day +1 -32.87% 2024-11-07 Day +5 -30.64% 2024-11-13 Best recovery within 5 -25.66% 2024-11-11 20.9% of the drop was recovered five sessions later. Month end -46.48% on 2024-11-29
Close before and after $29.54 to $18.09 Session open, high, low $17.84, $19.55, $16.74 Opening gap -39.61% Close inside the session range 0.48 of the range, where 1.00 is the high Session volume 9,814,327 shares, $177,541,175 Relative volume 15.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
26	LXRX release reads positive	-38.69%	2024-11-01 against the close of 2024-10-31 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory Release reads positive, stock fell 38.69%	Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease 10/31/2024 18:54 ET after hours	Day +1 -39.45% 2024-11-04 Day +5 -36.18% 2024-11-08 Best recovery within 5 -34.67% 2024-11-07 6.5% of the drop was recovered five sessions later. Month end -59.61% on 2024-11-29
Close before and after $1.99 to $1.22 Session open, high, low $1.20, $1.38, $1.16 Opening gap -39.95% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 20,999,962 shares, $25,619,954 Relative volume 7.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	DWTX	-37.71%	2024-11-18 against the close of 2024-11-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study 11/18/2024 08:45 ET premarket	Day +1 -12.46% 2024-11-19 Day +5 -9.76% 2024-11-25 Best recovery within 5 -8.75% 2024-11-21 74.1% of the drop was recovered five sessions later. Month end -19.19% on 2024-11-29
Close before and after $2.97 to $1.85 Session open, high, low $2.97, $3.07, $1.62 Opening gap 0.00% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 143,845 shares, $266,113 Relative volume 3.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
28	ALTO	-37.63%	2024-11-07 against the close of 2024-11-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Alto Ingredients, Inc. Enters CO2 Transportation and Sequestration Agreement with Vault 44.01 11/06/2024 16:05 ET after hours Alto Ingredients, Inc. Reports Third Quarter 2024 Results 11/06/2024	Day +1 -32.99% 2024-11-08 Day +5 -28.87% 2024-11-14 Best recovery within 5 -28.87% 2024-11-14 23.3% of the drop was recovered five sessions later. Month end -25.26% on 2024-11-29
Close before and after $1.94 to $1.21 Session open, high, low $1.60, $1.62, $1.18 Opening gap -17.53% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 7,653,669 shares, $9,260,939 Relative volume 19.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
29	TNGX	-37.45%	2024-11-06 against the close of 2024-11-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program 11/06/2024 07:00 ET premarket Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights 11/06/2024	Day +1 -45.37% 2024-11-07 Day +5 -31.27% 2024-11-13 Best recovery within 5 -31.27% 2024-11-13 16.5% of the drop was recovered five sessions later. Month end -23.94% on 2024-11-29
Close before and after $5.18 to $3.24 Session open, high, low $3.05, $3.94, $2.91 Opening gap -41.12% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 14,932,415 shares, $48,381,025 Relative volume 17.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
30	STIM	-37.27%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results 11/12/2024 07:10 ET premarket	Day +1 -44.58% 2024-11-13 Day +5 -31.35% 2024-11-19 Best recovery within 5 -28.18% 2024-11-14 15.9% of the drop was recovered five sessions later. Month end -9.09% on 2024-11-29
Close before and after $1.10 to $0.6900 Session open, high, low $0.7700, $0.8021, $0.5200 Opening gap -30.00% Close inside the session range 0.60 of the range, where 1.00 is the high Session volume 7,766,989 shares, $5,359,222 Relative volume 52.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
31	TVGNW release reads positive	-37.25%	2024-11-06 against the close of 2024-11-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 37.25%	Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability 11/05/2024 16:43 ET after hours	Day +1 -20.00% 2024-11-07 Day +5 -23.00% 2024-11-13 Best recovery within 5 -20.00% 2024-11-07 38.3% of the drop was recovered five sessions later. Month end -27.50% on 2024-11-29
Close before and after $0.0800 to $0.0502 Session open, high, low $0.0816, $0.0861, $0.0400 Opening gap +2.00% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 178,453 shares, $8,958 Relative volume 0.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	AIMDW More than one ranked move this month 2+ ranked moves	-37.13%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities 11/08/2024 08:00 ET premarket	Day +1 +26.49% 2024-12-09 Day +5 no data Best recovery within 5 so far +26.49% 2024-12-09 Month-end is not shown: no closing price is available for 2024-11-29.
Close before and after $0.0404 to $0.0254 Session open, high, low $0.0400, $0.0400, $0.0254 Opening gap -0.99% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 14 shares, $0 Baseline gap 1 calendar day from the pre-news close to the measured session
33	LILM	-36.97%	2024-11-05 against the close of 2024-11-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Lilium Launches M&A Process with KPMG, Targets Program Continuation Towards First Flight and Certification 11/05/2024 04:00 ET premarket	Day +1 no data Day +5 no data Best recovery within 5 no data Month-end is not shown: no closing price is available for 2024-11-29.
Close before and after $0.0825 to $0.0520 Session open, high, low $0.0775, $0.1009, $0.0497 Opening gap -6.06% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 82,794,280 shares, $4,305,303 Relative volume 4.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	ALVR	-36.93%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina 11/08/2024 06:00 ET premarket	Day +1 -24.71% 2024-11-11 Day +5 -42.03% 2024-11-15 Best recovery within 5 -24.71% 2024-11-11 The drop was 13.8% larger five sessions later. Month end -44.18% on 2024-11-29
Close before and after $22.57 to $14.24 Session open, high, low $15.32, $17.25, $13.81 Opening gap -32.14% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 93,771 shares, $1,335,018 Relative volume 9.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
35	KURA release reads positive	-36.77%	2024-11-21 against the close of 2024-11-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership Release reads positive, stock fell 36.77%	Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias 11/20/2024 17:00 ET after hours	Day +1 -32.12% 2024-11-22 Day +5 -30.61% 2024-11-29 Best recovery within 5 -29.79% 2024-11-27 16.8% of the drop was recovered five sessions later. Month end -30.61% on 2024-11-29
Close before and after $15.91 to $10.06 Session open, high, low $11.80, $12.24, $9.68 Opening gap -25.83% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 17,538,925 shares, $176,441,586 Relative volume 22.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
36	PIII	-35.99%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	P3 Health Partners Announces Third Quarter 2024 Results 11/12/2024 16:05 ET after hours	Day +1 -46.36% 2024-11-14 Day +5 -47.80% 2024-11-20 Best recovery within 5 -41.47% 2024-11-15 The drop was 32.8% larger five sessions later. Month end -35.99% on 2024-11-29
Close before and after $19.52 to $12.50 Session open, high, low $15.50, $17.25, $11.25 Opening gap -20.59% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 54,598 shares, $682,202 Relative volume 8.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	RVNC	-35.99%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update 11/07/2024 16:05 ET after hours	Day +1 -40.31% 2024-11-11 Day +5 -27.85% 2024-11-15 Best recovery within 5 -25.43% 2024-11-14 22.6% of the drop was recovered five sessions later. Month end -37.54% on 2024-11-29
Close before and after $5.78 to $3.70 Session open, high, low $4.25, $4.34, $3.48 Opening gap -26.47% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 13,145,829 shares, $48,639,567 Relative volume 11.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
38	SYM	-35.86%	2024-11-27 against the close of 2024-11-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Symbotic Provides Update to Restatement of Fiscal Year 2024 Financial Results and First Quarter of Fiscal Year 2025 Outlook 11/27/2024 07:00 ET premarket	Day +1 -28.09% 2024-11-29 Day +5 -25.39% 2024-12-05 Best recovery within 5 -25.39% 2024-12-05 29.2% of the drop was recovered five sessions later. Month end -28.09% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $37.41 to $24.00 Session open, high, low $25.07, $25.47, $21.78 Opening gap -32.99% Close inside the session range 0.60 of the range, where 1.00 is the high Session volume 21,916,637 shares, $525,889,705 Relative volume 16.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
39	PGY	-35.58%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Pagaya Reports Third Quarter and Nine Months Ended 2024 Results 11/12/2024 07:19 ET premarket	Day +1 -39.73% 2024-11-13 Day +5 -48.96% 2024-11-19 Best recovery within 5 -39.73% 2024-11-13 The drop was 37.6% larger five sessions later. Month end -35.29% on 2024-11-29
Close before and after $16.89 to $10.88 Session open, high, low $12.27, $12.27, $10.21 Opening gap -27.35% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 12,986,795 shares, $141,296,330 Relative volume 10.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
40	SSP	-35.51%	2024-11-04 against the close of 2024-11-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Scripps reports Q3 2024 financial results 11/04/2024 07:30 ET premarket Scripps earnings call number, time changed this morning due to conference line outage 11/04/2024	Day +1 -34.94% 2024-11-05 Day +5 -35.23% 2024-11-11 Best recovery within 5 -31.82% 2024-11-07 0.8% of the drop was recovered five sessions later. Month end -43.18% on 2024-11-29
Close before and after $3.52 to $2.27 Session open, high, low $3.80, $4.06, $2.12 Opening gap +7.95% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 4,267,702 shares, $9,687,684 Relative volume 9.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
41	MRVI	-35.27%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Maravai LifeSciences Reports Third Quarter 2024 Financial Results 11/07/2024 16:01 ET after hours Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research 11/07/2024	Day +1 -26.28% 2024-11-11 Day +5 -43.62% 2024-11-15 Best recovery within 5 -26.28% 2024-11-11 The drop was 23.7% larger five sessions later. Month end -27.68% on 2024-11-29
Close before and after $7.84 to $5.08 Session open, high, low $4.75, $5.15, $4.71 Opening gap -39.41% Close inside the session range 0.83 of the range, where 1.00 is the high Session volume 11,404,870 shares, $57,879,715 Relative volume 8.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
42	RAIL	-35.26%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	FreightCar America, Inc. Reports Third Quarter 2024 Results 11/12/2024 07:30 ET premarket	Day +1 -37.24% 2024-11-13 Day +5 -31.00% 2024-11-19 Best recovery within 5 -31.00% 2024-11-19 12.1% of the drop was recovered five sessions later. Month end -37.62% on 2024-11-29
Close before and after $15.71 to $10.17 Session open, high, low $12.80, $12.88, $9.34 Opening gap -18.52% Close inside the session range 0.23 of the range, where 1.00 is the high Session volume 2,478,588 shares, $25,207,240 Relative volume 5.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
43	ALEC	-35.10%	2024-11-26 against the close of 2024-11-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update 11/25/2024 16:05 ET after hours	Day +1 -35.73% 2024-11-27 Day +5 -44.70% 2024-12-04 Best recovery within 5 -34.60% 2024-11-29 The drop was 27.4% larger five sessions later. Month end -34.60% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $3.96 to $2.57 Session open, high, low $2.59, $2.71, $2.37 Opening gap -34.60% Close inside the session range 0.59 of the range, where 1.00 is the high Session volume 8,130,344 shares, $20,894,984 Relative volume 12.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
44	AVNW	-34.54%	2024-11-06 against the close of 2024-11-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Aviat Networks Announces Fiscal 2025 First Quarter and Three Month Financial Results 11/05/2024 16:01 ET after hours	Day +1 -33.78% 2024-11-07 Day +5 -30.24% 2024-11-13 Best recovery within 5 -30.24% 2024-11-13 12.4% of the drop was recovered five sessions later. Month end -24.37% on 2024-11-29
Close before and after $20.93 to $13.70 Session open, high, low $16.37, $16.77, $13.45 Opening gap -21.79% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 1,481,113 shares, $20,291,248 Relative volume 13.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
45	MFH release reads positive	-34.50%	2024-11-14 against the close of 2024-11-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads positive, stock fell 34.50%	Mercurity Fintech CEO Highlights Strategic Vision Following Participation in Nasdaq Small-Cap Forum 11/14/2024 09:05 ET premarket	Day +1 -30.64% 2024-11-15 Day +5 -24.77% 2024-11-21 Best recovery within 5 -24.77% 2024-11-21 28.2% of the drop was recovered five sessions later. Month end +29.91% on 2024-11-29
Close before and after $5.45 to $3.57 Session open, high, low $4.73, $4.73, $3.18 Opening gap -13.21% Close inside the session range 0.25 of the range, where 1.00 is the high Session volume 385,295 shares, $1,375,503 Relative volume 10.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
46	AGL	-34.05%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	agilon health Reports Third Quarter 2024 Results 11/07/2024 16:00 ET after hours	Day +1 -22.58% 2024-11-11 Day +5 -43.37% 2024-11-15 Best recovery within 5 -22.58% 2024-11-11 The drop was 27.4% larger five sessions later. Month end -25.09% on 2024-11-29
Close before and after $69.75 to $46.00 Session open, high, low $46.50, $50.50, $45.00 Opening gap -33.33% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 763,583 shares, $35,124,818 Relative volume 5.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
47	OPRX	-33.98%	2024-11-14 against the close of 2024-11-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	OptimizeRx Reports Third Quarter 2024 Financial Results 11/13/2024 16:05 ET after hours	Day +1 -37.80% 2024-11-15 Day +5 -26.99% 2024-11-21 Best recovery within 5 -26.99% 2024-11-21 20.6% of the drop was recovered five sessions later. Month end -11.38% on 2024-11-29
Close before and after $6.15 to $4.06 Session open, high, low $4.75, $4.78, $3.95 Opening gap -22.76% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 1,966,650 shares, $7,984,599 Relative volume 13.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	AMPGW More than one ranked move this month 2+ ranked moves	-33.88%	2024-11-27 against the close of 2024-11-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering 11/26/2024 16:00 ET after hours	Day +1 +31.82% 2024-11-29 Day +5 +854.55% 2024-12-11 Best recovery within 5 +854.55% 2024-12-11 It recovered the whole drop and closed 854.55% above the pre-news price. Month end +31.82% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $0.0242 to $0.0160 Session open, high, low $0.0160, $0.0160, $0.0160 Opening gap -33.88% Session volume 400 shares, $6 Relative volume 0.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
49	SWAGW Also on the opposite board this month on both boards	-33.75%	2024-11-25 against the close of 2024-11-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Stran & Company Receives Additional Notification of Deficiency From Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q 11/22/2024 16:30 ET after hours	Day +1 -33.75% 2024-12-02 Day +5 -37.50% 2024-12-10 Best recovery within 5 -26.25% 2024-12-03 The drop was 11.1% larger five sessions later. Month-end is not shown: no closing price is available for 2024-11-29. This month ended before the fifth session after the move.
Close before and after $0.0160 to $0.0106 Session open, high, low $0.0199, $0.0199, $0.0106 Opening gap +24.38% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 8,000 shares, $85 Relative volume 0.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
50	AMPGW More than one ranked move this month release reads positive 2+ ranked moves	-32.43% resumed after 14 days	2024-11-19 against the close of 2024-11-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership Release reads positive, stock fell 32.43%	AmpliTech Group's AmpliTech Inc. Division Secures Initial Purchase Order Under 5-Year Basic Order Agreement With Fortune 1000 U.S. Company 11/18/2024 08:30 ET premarket AmpliTech Group’s AmpliTech Inc Division Signs 5 Year BOA (Basic Order Agreement) With Fortune 1000 US Company For LNB Products 11/14/2024 AmpliTech Group Reports 2.8M revenue, 1.3M Gross profits, 47% Gross Margins 11/15/2024	Day +1 no data Day +5 no data Best recovery within 5 no data Month-end is not shown: no closing price is available for 2024-11-29.
This stock last traded 14 days before the measured session, so before-and-after prices and follow-through are not shown. Baseline gap 14 calendar days from the pre-news close to the measured session
51	AIMDW More than one ranked move this month 2+ ranked moves	-31.41%	2024-11-07 against the close of 2024-10-31 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Ainos Reports Third Quarter 2024 Financial Results 11/06/2024 16:30 ET after hours	Day +1 -56.88% 2024-11-08 Day +5 no data Best recovery within 5 so far -13.24% 2024-12-09 Month-end is not shown: no closing price is available for 2024-11-29.
Close before and after $0.0589 to $0.0404 Session open, high, low $0.0570, $0.0570, $0.0404 Opening gap -3.23% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 42 shares, $2 Baseline gap 7 calendar days from the pre-news close to the measured session
52	MAMO	-31.25%	2024-11-15 against the close of 2024-11-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Massimo Group Reports Third Quarter 2024 Financial Results 11/15/2024 08:31 ET premarket	Day +1 -31.01% 2024-11-18 Day +5 -22.60% 2024-11-22 Best recovery within 5 -22.60% 2024-11-22 27.7% of the drop was recovered five sessions later. Month end -19.47% on 2024-11-29
Close before and after $4.16 to $2.86 Session open, high, low $3.44, $3.99, $2.74 Opening gap -17.31% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 293,786 shares, $840,228 Relative volume 1.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
53	OPTX	-31.13%	2024-11-15 against the close of 2024-11-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Third Quarter 2024 Financial Results 11/14/2024 16:37 ET after hours Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update 11/15/2024	Day +1 -34.43% 2024-11-18 Day +5 -42.02% 2024-11-22 Best recovery within 5 -34.43% 2024-11-18 The drop was 35.0% larger five sessions later. Month end -41.46% on 2024-11-29
Close before and after $1.51 to $1.04 Session open, high, low $1.30, $1.30, $1.01 Opening gap -13.91% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 304,785 shares, $316,976 Relative volume 13.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	AREBW release reads positive	-31.03%	2024-11-05 against the close of 2024-11-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership Release reads positive, stock fell 31.03%	American Rebel Supports Metro Nashville Police Department’s 30th Annual Toy Parade in collaboration with Boswell’s Harley-Davidson – American Rebel Light Beer Featured at Nashville’s Scoreboard Opry Bar & Grill Afterparty 11/05/2024 08:00 ET premarket	Day +1 -24.83% 2024-11-06 Day +5 -34.48% 2024-11-12 Best recovery within 5 -3.46% 2024-11-07 The drop was 11.1% larger five sessions later. Month-end is not shown: no closing price is available for 2024-11-29.
Close before and after $1.45 to $1.00 Session open, high, low $1.01, $1.01, $0.9100 Opening gap -30.34% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 87 shares, $87 Relative volume 1.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
55	HRTX	-30.43%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance 11/12/2024 07:55 ET premarket	Day +1 -34.24% 2024-11-13 Day +5 -35.33% 2024-11-19 Best recovery within 5 -32.61% 2024-11-14 The drop was 16.1% larger five sessions later. Month end -35.33% on 2024-11-29
Close before and after $1.84 to $1.28 Session open, high, low $1.04, $1.53, $1.04 Opening gap -43.48% Close inside the session range 0.49 of the range, where 1.00 is the high Session volume 10,605,641 shares, $13,575,220 Relative volume 9.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
56	JELD	-29.79%	2024-11-05 against the close of 2024-11-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	JELD-WEN Reports Third Quarter 2024 Results 11/04/2024 16:30 ET after hours	Day +1 -23.07% 2024-11-06 Day +5 -24.63% 2024-11-12 Best recovery within 5 -20.03% 2024-11-11 17.3% of the drop was recovered five sessions later. Month end -22.93% on 2024-11-29
Close before and after $14.13 to $9.92 Session open, high, low $10.54, $10.85, $8.90 Opening gap -25.41% Close inside the session range 0.52 of the range, where 1.00 is the high Session volume 5,594,921 shares, $55,501,616 Relative volume 15.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
57	HTLM	-29.56%	2024-11-25 against the close of 2024-11-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	HomesToLife Ltd Announces Financial Results for First Six Months of 2024; Company to hold Conference Call to Discuss Results Nov. 26 at 8:30 am ET 11/25/2024 07:14 ET premarket	Day +1 -17.48% 2024-11-26 Day +5 +7.67% 2024-12-03 Best recovery within 5 +17.48% 2024-11-27 It recovered the whole drop and closed 7.67% above the pre-news price. Month end +2.39% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $3.98 to $2.80 Session open, high, low $3.99, $4.04, $2.57 Opening gap +0.38% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 213,602 shares, $598,086 Relative volume 5.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
58	QUBT Also on the opposite board this month on both boards	-29.55%	2024-11-15 against the close of 2024-11-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Quantum Computing, Inc. Announces Registered Direct Offering of $40 Million Priced At-The-Market Under Nasdaq Rules 11/14/2024 23:00 ET after hours	Day +1 -45.68% 2024-11-18 Day +5 +38.64% 2024-11-22 Best recovery within 5 +38.64% 2024-11-22 It recovered the whole drop and closed 38.64% above the pre-news price. Month end +60.45% on 2024-11-29
Close before and after $4.40 to $3.10 Session open, high, low $2.93, $3.21, $2.53 Opening gap -33.41% Close inside the session range 0.84 of the range, where 1.00 is the high Session volume 53,358,059 shares, $165,409,983 Relative volume 14.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
59	PAVMZ Also on the opposite board this month on both boards	-29.31%	2024-11-14 against the close of 2024-11-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	PAVmed Provides Business Update and Third Quarter 2024 Financial Results 11/14/2024 08:01 ET premarket	Day +1 -29.31% 2024-11-18 Day +5 -50.13% 2024-12-02 Best recovery within 5 -29.31% 2024-11-18 The drop was 71.0% larger five sessions later. Month-end is not shown: no closing price is available for 2024-11-29. This month ended before the fifth session after the move.
Close before and after $0.0389 to $0.0275 Session open, high, low $0.0151, $0.0275, $0.0151 Opening gap -61.18% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 890 shares, $24 Baseline gap 1 calendar day from the pre-news close to the measured session
60	AMN	-29.01%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AMN Healthcare Announces Third Quarter 2024 Results 11/07/2024 16:15 ET after hours	Day +1 -32.06% 2024-11-11 Day +5 -42.08% 2024-11-15 Best recovery within 5 -32.06% 2024-11-11 The drop was 45.1% larger five sessions later. Month end -36.39% on 2024-11-29
Close before and after $40.92 to $29.05 Session open, high, low $36.25, $36.52, $28.16 Opening gap -11.41% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 5,472,787 shares, $158,984,462 Relative volume 8.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
61	LCTX	-28.99%	2024-11-20 against the close of 2024-11-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering 11/20/2024 08:00 ET premarket	Day +1 -33.57% 2024-11-21 Day +5 -37.02% 2024-11-27 Best recovery within 5 -33.02% 2024-11-26 The drop was 27.7% larger five sessions later. Month end -36.68% on 2024-11-29
Close before and after $0.9032 to $0.6414 Session open, high, low $0.7370, $0.7370, $0.6100 Opening gap -18.40% Close inside the session range 0.25 of the range, where 1.00 is the high Session volume 9,926,040 shares, $6,366,562 Relative volume 24.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
62	NRGV	-28.86%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Energy Vault Reports Third Quarter 2024 Financial Results 11/12/2024 16:05 ET after hours	Day +1 -17.41% 2024-11-14 Day +5 -26.37% 2024-11-20 Best recovery within 5 -17.41% 2024-11-14 8.6% of the drop was recovered five sessions later. Month end +2.49% on 2024-11-29
Close before and after $2.01 to $1.43 Session open, high, low $1.94, $1.96, $1.39 Opening gap -3.48% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 2,677,912 shares, $3,829,414 Relative volume 1.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
63	LEU	-28.79%	2024-11-04 against the close of 2024-11-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Centrus Announces Proposed Private Offering of $350 Million of Convertible Senior Notes due 2030 11/04/2024 06:52 ET premarket	Day +1 -30.86% 2024-11-05 Day +5 -16.38% 2024-11-11 Best recovery within 5 -16.22% 2024-11-08 43.1% of the drop was recovered five sessions later. Month end -16.92% on 2024-11-29
Close before and after $109.53 to $78.00 Session open, high, low $93.50, $94.99, $76.00 Opening gap -14.64% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 5,727,338 shares, $446,732,364 Relative volume 5.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
64	BRAG	-28.54%	2024-11-14 against the close of 2024-11-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Bragg Gaming Group Announces Record Third Quarter 2024 Revenue of EUR 26.2 Million (USD 29.3 Million) 11/14/2024 07:00 ET premarket	Day +1 -29.68% 2024-11-15 Day +5 -26.03% 2024-11-21 Best recovery within 5 -23.74% 2024-11-19 8.8% of the drop was recovered five sessions later. Month end -25.11% on 2024-11-29
Close before and after $4.38 to $3.13 Session open, high, low $3.99, $3.99, $2.95 Opening gap -8.90% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 645,970 shares, $2,021,886 Relative volume 17.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
65	BW	-28.46%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Babcock & Wilcox Enterprises Reports Third Quarter 2024 Results 11/12/2024 16:34 ET after hours	Day +1 -27.27% 2024-11-14 Day +5 -22.13% 2024-11-20 Best recovery within 5 -21.34% 2024-11-19 22.2% of the drop was recovered five sessions later. Month end -21.74% on 2024-11-29
Close before and after $2.53 to $1.81 Session open, high, low $2.15, $2.16, $1.71 Opening gap -15.02% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 4,516,564 shares, $8,174,981 Relative volume 3.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
66	FIGS	-28.34%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	FIGS Releases Third Quarter 2024 Financial Results 11/07/2024 16:05 ET after hours	Day +1 -28.79% 2024-11-11 Day +5 -26.24% 2024-11-15 Best recovery within 5 -24.14% 2024-11-13 7.4% of the drop was recovered five sessions later. Month end -22.19% on 2024-11-29
Close before and after $6.67 to $4.78 Session open, high, low $5.01, $5.03, $4.42 Opening gap -24.89% Close inside the session range 0.59 of the range, where 1.00 is the high Session volume 15,999,144 shares, $76,475,908 Relative volume 10.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	ARQQW release reads positive	-28.28%	2024-11-26 against the close of 2024-11-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings Release reads positive, stock fell 28.28%	Arqit Sets Fiscal Year 2024 Conference Call for Thursday, December 5, 2024 at 11:00 a.m. ET 11/26/2024 13:00 ET intraday	Day +1 -24.36% 2024-11-27 Day +5 +3.45% 2024-12-04 Best recovery within 5 +7.43% 2024-12-03 It recovered the whole drop and closed 3.45% above the pre-news price. Month end -26.56% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $0.4495 to $0.3224 Session open, high, low $0.2502, $0.4398, $0.2502 Opening gap -44.34% Close inside the session range 0.38 of the range, where 1.00 is the high Session volume 136,041 shares, $43,860 Relative volume 5.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
68	LPSN	-28.20%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	LivePerson Announces Third Quarter 2024 Financial Results 11/07/2024 16:30 ET after hours	Day +1 -26.46% 2024-11-11 Day +5 -35.81% 2024-11-15 Best recovery within 5 -26.46% 2024-11-11 The drop was 27.0% larger five sessions later. Month end -19.79% on 2024-11-29
Close before and after $18.15 to $13.03 Session open, high, low $17.40, $17.69, $11.72 Opening gap -4.13% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 761,216 shares, $9,920,167 Relative volume 9.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
69	TISI	-28.11%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Team, Inc. Reports Third Quarter 2024 Results 11/11/2024 16:45 ET after hours	Day +1 -33.26% 2024-11-13 Day +5 -24.23% 2024-11-19 Best recovery within 5 -24.23% 2024-11-19 13.8% of the drop was recovered five sessions later. Month end -21.05% on 2024-11-29
Close before and after $21.38 to $15.37 Session open, high, low $21.00, $21.00, $14.35 Opening gap -1.78% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 118,710 shares, $1,824,573 Relative volume 3.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	NAMSW	-27.92%	2024-11-20 against the close of 2024-11-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH 11/20/2024 07:00 ET premarket	Day +1 -31.20% 2024-11-21 Day +5 -26.09% 2024-11-27 Best recovery within 5 -22.58% 2024-11-25 6.6% of the drop was recovered five sessions later. Month end -30.89% on 2024-11-29
Close before and after $13.11 to $9.45 Session open, high, low $11.10, $11.10, $9.13 Opening gap -15.33% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 31,746 shares, $300,000 Relative volume 5.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
71	PACS More than one ranked move this month 2+ ranked moves	-27.78%	2024-11-04 against the close of 2024-11-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	PACS Group Closes Acquisition of Operations at 8 Facilities in Pennsylvania, Including Real Estate on 4 11/01/2024 16:05 ET after hours	Day +1 -31.21% 2024-11-05 Day +5 -48.86% 2024-11-11 Best recovery within 5 -31.21% 2024-11-05 The drop was 75.9% larger five sessions later. Month end -63.18% on 2024-11-29
Close before and after $42.94 to $31.01 Session open, high, low $41.37, $43.37, $22.30 Opening gap -3.66% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 13,886,668 shares, $430,625,575 Relative volume 22.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
72	FMSTW release reads positive	-27.70%	2024-11-20 against the close of 2024-11-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership Release reads positive, stock fell 27.70%	Foremost Clean Energy Corrects Red Cloud Contract and Provides Details For Its Plan of Arrangement 11/20/2024 08:30 ET premarket	Day +1 -39.24% 2024-11-22 Day +5 no data Best recovery within 5 so far -17.75% 2024-12-04 Month-end is not shown: no closing price is available for 2024-11-29.
Close before and after $0.3950 to $0.2856 Session open, high, low $0.3200, $0.4000, $0.2600 Opening gap -18.99% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 6,342 shares, $1,811 Relative volume 8.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
73	LTRX	-27.69%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Lantronix Reports Results for First Quarter of Fiscal 2025 11/07/2024 16:15 ET after hours Lantronix Accelerates IoT Leadership With Strategic Acquisition of DZS’s NetComm Enterprise IoT Portfolio 11/07/2024	Day +1 -33.33% 2024-11-11 Day +5 -27.44% 2024-11-15 Best recovery within 5 -27.44% 2024-11-15 0.9% of the drop was recovered five sessions later. Month end -23.08% on 2024-11-29
Close before and after $3.90 to $2.82 Session open, high, low $3.18, $3.18, $2.65 Opening gap -18.46% Close inside the session range 0.32 of the range, where 1.00 is the high Session volume 2,109,878 shares, $5,949,856 Relative volume 11.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
74	MDAIW Also on the opposite board this month on both boards	-27.67%	2024-11-21 against the close of 2024-11-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Spectral AI Announces DeepView SnapShot® M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research 11/21/2024 08:00 ET premarket	Day +1 -16.33% 2024-11-22 Day +5 +163.33% 2024-11-29 Best recovery within 5 +163.33% 2024-11-29 It recovered the whole drop and closed 163.33% above the pre-news price. Month end +163.33% on 2024-11-29
Close before and after $0.1500 to $0.1085 Session open, high, low $0.1496, $0.1496, $0.1000 Opening gap -0.27% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 119,059 shares, $12,918 Relative volume 9.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
75	LEV	-27.67%	2024-11-07 against the close of 2024-11-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	LION ELECTRIC ANNOUNCES THIRD QUARTER 2024 RESULTS 11/06/2024 17:05 ET after hours	Day +1 -39.12% 2024-11-08 Day +5 -36.84% 2024-11-14 Best recovery within 5 -29.82% 2024-11-11 The drop was 33.1% larger five sessions later. Month end -67.61% on 2024-11-29
Close before and after $0.5700 to $0.4123 Session open, high, low $0.5015, $0.5129, $0.4123 Opening gap -12.02% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 2,173,917 shares, $896,306 Relative volume 13.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
76	CLVT	-27.16%	2024-11-06 against the close of 2024-11-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Clarivate Reports Third Quarter 2024 Results 11/06/2024 06:00 ET premarket	Day +1 -28.98% 2024-11-07 Day +5 -27.92% 2024-11-13 Best recovery within 5 -27.92% 2024-11-13 The drop was 2.8% larger five sessions later. Month end -13.05% on 2024-11-29
Close before and after $6.59 to $4.80 Session open, high, low $5.25, $5.43, $4.57 Opening gap -20.33% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 27,338,285 shares, $131,223,768 Relative volume 11.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
77	GRPN	-27.03%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Groupon Announces $197 Million Financing Transaction 11/12/2024 16:57 ET after hours Groupon Reports Third Quarter 2024 Results 11/12/2024	Day +1 -26.63% 2024-11-14 Day +5 -24.91% 2024-11-20 Best recovery within 5 -21.55% 2024-11-19 7.8% of the drop was recovered five sessions later. Month end -17.14% on 2024-11-29
Close before and after $11.32 to $8.26 Session open, high, low $8.75, $8.91, $7.75 Opening gap -22.70% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 8,159,511 shares, $67,397,561 Relative volume 8.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
78	AILE	-27.00%	2024-11-18 against the close of 2024-11-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	iLearningEngines Announces Leadership Appointments 11/18/2024 09:30 ET intraday	Day +1 -28.00% 2024-11-19 Day +5 +2.00% 2024-11-25 Best recovery within 5 +2.00% 2024-11-25 It recovered the whole drop and closed 2.00% above the pre-news price. Month end -8.00% on 2024-11-29
Close before and after $1.50 to $1.10 Session open, high, low $1.49, $1.50, $0.7000 Opening gap -0.67% Close inside the session range 0.49 of the range, where 1.00 is the high Session volume 5,965,931 shares, $6,532,694 Relative volume 11.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
79	CATO	-26.81%	2024-11-22 against the close of 2024-11-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	THE CATO CORPORATION SUSPENDS REGULAR QUARTERLY DIVIDEND 11/22/2024 07:00 ET premarket	Day +1 -31.25% 2024-11-25 Day +5 -36.09% 2024-12-02 Best recovery within 5 -31.25% 2024-11-25 The drop was 34.6% larger five sessions later. Month end -35.69% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $4.96 to $3.63 Session open, high, low $4.23, $4.37, $3.35 Opening gap -14.72% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 955,505 shares, $3,468,483 Relative volume 16.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
80	CURI	-26.62%	2024-11-07 against the close of 2024-11-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	CuriosityStream Reports Q3 2024 Earnings Results 11/06/2024 16:05 ET after hours	Day +1 -25.10% 2024-11-08 Day +5 -38.02% 2024-11-14 Best recovery within 5 -25.10% 2024-11-08 The drop was 42.8% larger five sessions later. Month end -30.42% on 2024-11-29
Close before and after $2.63 to $1.93 Session open, high, low $2.25, $2.37, $1.58 Opening gap -14.45% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 1,127,015 shares, $2,175,139 Relative volume 4.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
81	NXGLW	-26.55%	2024-11-14 against the close of 2024-11-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially 11/13/2024 16:40 ET after hours	Day +1 -26.21% 2024-11-15 Day +5 -29.01% 2024-11-21 Best recovery within 5 -23.44% 2024-11-19 The drop was 9.3% larger five sessions later. Month end -30.40% on 2024-11-29
Close before and after $0.7184 to $0.5277 Session open, high, low $0.6750, $0.8000, $0.5274 Opening gap -6.04% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 5,002 shares, $2,640 Relative volume 0.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	ANGI	-26.34%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	IAC Earnings Release and Letter to Shareholders Available on Company's Website 11/11/2024 16:10 ET after hours Angi Inc. Earnings Release Available on Company's Website 11/11/2024	Day +1 -29.58% 2024-11-13 Day +5 -24.43% 2024-11-19 Best recovery within 5 -24.43% 2024-11-19 7.3% of the drop was recovered five sessions later. Month end -29.01% on 2024-11-29
Close before and after $26.20 to $19.30 Session open, high, low $23.60, $23.60, $18.80 Opening gap -9.92% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 458,781 shares, $8,854,473 Relative volume 15.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
83	CE	-26.32%	2024-11-05 against the close of 2024-11-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Celanese Corporation Reports Third Quarter Earnings 11/04/2024 16:13 ET after hours	Day +1 -25.15% 2024-11-06 Day +5 -38.70% 2024-11-12 Best recovery within 5 -25.15% 2024-11-06 The drop was 47.0% larger five sessions later. Month end -40.72% on 2024-11-29
Close before and after $123.50 to $91.00 Session open, high, low $99.86, $102.00, $90.51 Opening gap -19.14% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 10,733,470 shares, $976,745,770 Relative volume 16.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
84	SPNS	-26.24%	2024-11-11 against the close of 2024-11-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sapiens Reports Third Quarter 2024 Financial Results 11/11/2024 05:43 ET premarket	Day +1 -28.75% 2024-11-12 Day +5 -31.18% 2024-11-18 Best recovery within 5 -27.60% 2024-11-14 The drop was 18.8% larger five sessions later. Month end -30.72% on 2024-11-29
Close before and after $39.45 to $29.10 Session open, high, low $29.80, $30.00, $28.88 Opening gap -24.46% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 839,627 shares, $24,433,146 Relative volume 13.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
85	GTN	-26.08%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Gray Announces Third Quarter Financial Results, Additional Cost Containment Initiatives, and Approximately $500 Million of Full-Year 2024 Political Ad Revenue and Projected $500 Million Full-Year 2024 Net Debt Reduction 11/08/2024 06:00 ET premarket GRAY ANNOUNCES QUARTERLY CASH DIVIDEND OF $0.08 PER SHARE 11/08/2024	Day +1 -22.11% 2024-11-11 Day +5 -19.00% 2024-11-15 Best recovery within 5 -17.27% 2024-11-14 27.1% of the drop was recovered five sessions later. Month end -26.25% on 2024-11-29
Close before and after $5.79 to $4.28 Session open, high, low $4.72, $4.72, $3.95 Opening gap -18.48% Close inside the session range 0.43 of the range, where 1.00 is the high Session volume 7,068,845 shares, $30,254,657 Relative volume 9.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
86	EVAX	-26.05%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing 11/13/2024 08:00 ET premarket	Day +1 -29.41% 2024-11-14 Day +5 -41.18% 2024-11-20 Best recovery within 5 -29.41% 2024-11-14 The drop was 58.1% larger five sessions later. Month end -30.25% on 2024-11-29
Close before and after $11.90 to $8.80 Session open, high, low $11.70, $11.70, $7.95 Opening gap -1.68% Close inside the session range 0.23 of the range, where 1.00 is the high Session volume 36,260 shares, $319,088 Relative volume 12.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
87	YOU	-25.80%	2024-11-07 against the close of 2024-11-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	CLEAR Announces Third Quarter 2024 Earnings 11/07/2024 06:00 ET premarket	Day +1 -27.78% 2024-11-08 Day +5 -30.01% 2024-11-14 Best recovery within 5 -27.57% 2024-11-11 The drop was 16.3% larger five sessions later. Month end -32.69% on 2024-11-29
Close before and after $38.45 to $28.53 Session open, high, low $31.24, $31.52, $28.36 Opening gap -18.75% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 10,239,352 shares, $292,128,713 Relative volume 5.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
88	DTSTW release reads positive	-25.69%	2024-11-14 against the close of 2024-11-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings Release reads positive, stock fell 25.69%	Data Storage Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update 11/14/2024 04:00 ET premarket	Day +1 -32.31% 2024-11-15 Day +5 -37.84% 2024-11-21 Best recovery within 5 -28.39% 2024-11-18 The drop was 47.3% larger five sessions later. Month end -49.49% on 2024-11-29
Close before and after $0.7400 to $0.5499 Session open, high, low $0.6500, $0.7100, $0.4350 Opening gap -12.16% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 13,890 shares, $7,638 Relative volume 8.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
89	TLPH	-25.61%	2024-11-14 against the close of 2024-11-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update 11/13/2024 16:05 ET after hours	Day +1 -22.46% 2024-11-15 Day +5 -21.44% 2024-11-21 Best recovery within 5 -20.63% 2024-11-20 16.3% of the drop was recovered five sessions later. Month end -20.56% on 2024-11-29
Close before and after $0.8900 to $0.6621 Session open, high, low $0.8700, $0.9080, $0.6505 Opening gap -2.25% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 410,074 shares, $271,510 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	SNDX	-25.57%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Syndax Announces Positive Pivotal Topline Results from Relapsed or Refractory mNPM1 AML Cohort in AUGMENT-101 Trial of Revumenib 11/12/2024 07:00 ET premarket	Day +1 -23.65% 2024-11-13 Day +5 -27.59% 2024-11-19 Best recovery within 5 -22.91% 2024-11-14 The drop was 7.9% larger five sessions later. Month end -23.23% on 2024-11-29
Close before and after $21.78 to $16.21 Session open, high, low $16.27, $17.35, $16.12 Opening gap -25.30% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 8,373,184 shares, $135,729,313 Relative volume 12.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
91	LTBR	-25.51%	2024-11-01 against the close of 2024-10-31 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Lightbridge Provides Business Update and Announces Third Quarter 2024 Financial Results 10/31/2024 16:05 ET after hours	Day +1 -26.49% 2024-11-04 Day +5 -7.61% 2024-11-08 Best recovery within 5 +0.21% 2024-11-07 70.2% of the drop was recovered five sessions later. Month end -32.72% on 2024-11-29
Close before and after $9.72 to $7.24 Session open, high, low $10.35, $11.12, $7.00 Opening gap +6.48% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 3,891,101 shares, $28,171,571 Relative volume 2.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
92	PSFE	-25.32%	2024-11-13 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Paysafe Reports Third Quarter 2024 Results; Reaffirms Full Year Outlook 11/13/2024 06:55 ET premarket	Day +1 -29.01% 2024-11-14 Day +5 -33.29% 2024-11-20 Best recovery within 5 -29.01% 2024-11-14 The drop was 31.5% larger five sessions later. Month end -21.95% on 2024-11-29
Close before and after $25.47 to $19.02 Session open, high, low $20.80, $20.82, $18.50 Opening gap -18.34% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 1,865,934 shares, $35,490,065 Relative volume 11.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
93	COMM	-25.18%	2024-11-07 against the close of 2024-11-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	CommScope Reports Third Quarter 2024 Results 11/07/2024 06:30 ET premarket	Day +1 -32.37% 2024-11-08 Day +5 -36.12% 2024-11-14 Best recovery within 5 -31.73% 2024-11-11 The drop was 43.4% larger five sessions later. Month end -31.37% on 2024-11-29
Close before and after $6.95 to $5.20 Session open, high, low $6.01, $6.08, $4.76 Opening gap -13.60% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 20,972,633 shares, $109,057,692 Relative volume 5.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
94	JRVR	-25.08%	2024-11-12 against the close of 2024-11-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	James River Announces Third Quarter 2024 Results, Strategic Actions 11/11/2024 16:10 ET after hours	Day +1 -30.51% 2024-11-13 Day +5 -32.78% 2024-11-19 Best recovery within 5 -28.40% 2024-11-14 The drop was 30.7% larger five sessions later. Month end -29.15% on 2024-11-29
Close before and after $6.62 to $4.96 Session open, high, low $6.14, $6.14, $4.80 Opening gap -7.25% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 1,822,816 shares, $9,041,167 Relative volume 9.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
95	AMPG	-25.00%	2024-11-25 against the close of 2024-11-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	AmpliTech Group Announces Pricing of $1.4 Million Registered Direct Offering, Priced At-The-Market 11/25/2024 09:00 ET premarket	Day +1 -27.27% 2024-11-26 Day +5 -28.43% 2024-12-03 Best recovery within 5 -24.27% 2024-11-29 The drop was 13.7% larger five sessions later. Month end -24.27% on 2024-11-29 This month ended before the fifth session after the move.
Close before and after $1.24 to $0.9300 Session open, high, low $0.9768, $1.07, $0.9100 Opening gap -21.23% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 702,044 shares, $652,901 Relative volume 19.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
96	GDHG	-25.00%	2024-11-19 against the close of 2024-11-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Golden Heaven Group Holdings Ltd. Secures Investment of US$25.2 Million and Enters Into Amendments to Outstanding Warrants 11/19/2024 09:00 ET premarket	Day +1 -26.47% 2024-11-20 Day +5 -19.12% 2024-11-26 Best recovery within 5 -19.12% 2024-11-26 23.5% of the drop was recovered five sessions later. Month end -22.55% on 2024-11-29
Close before and after $765.00 to $573.75 Session open, high, low $641.25, $690.00, $547.50 Opening gap -16.18% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 845 shares, $484,819 Relative volume 4.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
97	JFBRW	-24.90%	2024-11-15 against the close of 2024-11-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Jeffs’ Brands Subsidiary, Fort Products, Embraces the Future of E-Commerce 11/14/2024 06:55 ET premarket	Day +1 -3.04% 2024-11-19 Day +5 -4.86% 2024-11-26 Best recovery within 5 -3.04% 2024-11-19 80.5% of the drop was recovered five sessions later. Month end -10.93% on 2024-11-29
Close before and after $0.0494 to $0.0371 Session open, high, low $0.0371, $0.0371, $0.0371 Opening gap -24.90% Session volume 2,018 shares, $75 Relative volume 0.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
98	SCWO	-24.82%	2024-11-15 against the close of 2024-11-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	374Water Inc. Announces Pricing of $12.2 Million Registered Direct Offering 11/15/2024 08:00 ET premarket	Day +1 -24.82% 2024-11-18 Day +5 -26.28% 2024-11-22 Best recovery within 5 -24.82% 2024-11-18 The drop was 5.9% larger five sessions later. Month end -28.18% on 2024-11-29
Close before and after $13.70 to $10.30 Session open, high, low $13.60, $13.80, $10.20 Opening gap -0.73% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 85,916 shares, $884,935 Relative volume 7.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
99	CRDF	-24.69%	2024-11-08 against the close of 2024-11-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update 11/07/2024 16:05 ET after hours	Day +1 -15.40% 2024-11-11 Day +5 -36.92% 2024-11-15 Best recovery within 5 -15.40% 2024-11-11 The drop was 49.5% larger five sessions later. Month end -36.19% on 2024-11-29
Close before and after $4.09 to $3.08 Session open, high, low $4.13, $4.23, $2.85 Opening gap +0.98% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 3,658,061 shares, $11,266,828 Relative volume 5.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
100	OKLO	-24.62%	2024-11-15 against the close of 2024-11-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Oklo Publishes Third Quarter 2024 Financial Results and Business Update 11/14/2024 16:05 ET after hours	Day +1 -13.44% 2024-11-18 Day +5 +5.53% 2024-11-22 Best recovery within 5 +5.65% 2024-11-21 It recovered the whole drop and closed 5.53% above the pre-news price. Month end -1.42% on 2024-11-29
Close before and after $23.88 to $18.00 Session open, high, low $21.00, $21.05, $17.31 Opening gap -12.06% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 36,342,759 shares, $654,169,662 Relative volume 1.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. 914 smaller events are excluded; switch to include them. Include the $5M to $25M band

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In November 2024, the median decliner had recovered 3.1% of its drop five sessions later; the largest catalyst group was Earnings, 51 of the 100 events, at a median of -29.0%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still below the pre-news close at day +5
Earnings	51	51.0%	-29.0%	-31.3% of 50	94.0% of 50
Other Announcement	16	16.0%	-37.2%	-23.0% of 13	84.6% of 13
Clinical Trial Results	13	13.0%	-45.0%	-44.7%	100.0% of 13
Offering / Dilution	8	8.0%	Fewer than 10 events in this group, so no figures are shown.
Contract / Partnership	5	5.0%	Fewer than 10 events in this group, so no figures are shown.

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

5 other catalyst types, 7 events: M&A / Acquisition, FDA & Regulatory, Uplisting / Compliance, Buyback / Dividend, Leadership Change.

How much of the drop held

Horizon	Still below the pre-news close close to close	Median change since the measured close as a share of the drop
Day +1	98.0% of 98	1.0% deeper below baseline, of 98
Day +5	92.6% of 94	3.1% recovered, of 94
Month end	93.3% of 89	9.2% recovered, of 89
Month end falls before day +5 for 10 of these 89 events, so this row is not a later horizon than the one above it. 89 of the 100 events have a month-end close later than the measured session; 11 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside November 2024

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Largest drop
NGNE	2Clinical Trial Results	-44.08%
PACS	2Other Announcement, M&A / Acquisition	-38.76%
AIMDW	2Other Announcement, Earnings	-37.13%
AMPGW	2Offering / Dilution, Contract / Partnership	-33.88%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Largest drop
STEM	2024-10, 2024-09, 2024-08	-40.81%
HOVRW	2024-10, 2024-09, 2024-08	-41.79%
AREBWthis month too	2024-10, 2024-09, 2024-08	-34.71%
LASE	2024-10, 2024-09	-38.81%
SVMHW	2024-10, 2024-09	-36.97%
SYTAW	2024-10, 2024-09	-36.14%
WLDSW	2024-10, 2024-09	-38.11%
EDBLW	2024-10, 2024-09	-66.44%
AMPGWthis month too	2024-10, 2024-09	-43.38%
SXTPW	2024-10, 2024-09	-37.46%
HSDT	2024-10, 2024-09	-22.05%
UAVS	2024-10, 2024-09	-64.57%
SABSW	2024-09, 2024-08	-45.26%
FFIE	2024-09, 2024-08	-31.74%
CLOER	2024-09, 2024-08	-25.77%
CLNN	2024-09, 2024-08	-23.47%

What the board was made of

Price before the move

1 event has no pre-news close, and is not in the bands above.

When the announcement landed

Volume against normal

4 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

41 other industries, 46 events

Industry not known: 12.0%

10 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against October 2024

98 events in the comparable window.

October 2024 median -24.8%, selected from 10,081 qualifying events

November 2024 median -31.9%, 7.1 points steeper than October 2024. November 2024's median is taken over the 100 ranked rows, selected from 9,235 qualifying events.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.